ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics, Ltd. (IMUC) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 59 transactions totaling $1.4M, demonstrating a bearish sentiment with -$1.2M in net insider flow. The most recent transaction on Jun 6, 2018 involved a transaction of 120,000 shares valued at $0.
IMUC Insider Activity Summary
Who Is Buying IMUC Stock?
No significant insider buying has been recorded for IMUC in the recent period.
Who Is Selling IMUC Stock?
No significant insider selling has been recorded for IMUC in the recent period.
Is ImmunoCellular Therapeutics, Ltd. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IMUC is bearish with an Insider Alignment Score of 8/100 and a net flow of -$1.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
IMUC Frequently Asked Questions
Understanding IMUC Insider Activity
Insider trading at ImmunoCellular Therapeutics, Ltd. (IMUC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading IMUC stock, having executed 59 transactions in the past 90 days. The most active insider is John S. Yu (Executive), who has made 17 transactions totaling $959.9K.
Related Tools
Track ImmunoCellular Therapeutics, Ltd. Insider Activity
Get notified when executives and directors at IMUC file new Form 4 transactions